Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2023-06-27 00:00:00 ET · period of report 2023-06-23 · accession 0001493152-23-022668 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-27 | 2023-06-23 | IMDX | Arno Andrew | Dir | A - Grant | $0.00 | +30.0K | 703.1K | +4% | $0 |
| D | 2023-06-27 | 2023-06-23 | IMDX | Arno Andrew | Dir | A - Grant | $0.00 | +135.0K | 135.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2023-06-23 | A | A | 30,000 | $0.00 | 703,133 | D | — | — | (F1) The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. |
| 2 | Derivative | Option to Purchase Common Stock | 2023-06-23 | A | A | 135,000 | $0.00 | 135,000 | D | $0.2 · — to 2033-06-23 | 135,000 Common Stock | (F4) Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. |